secwatch.observer — SEC 8-K summary
======================================

Issuer:     Q32 Bio Inc. (QTTB)
CIK:        0001661998
Form:       8-K
Filed at:   2025-05-23T23:59:59+00:00
Accession:  0001193125-25-125435
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Q32 Bio receives Nasdaq delisting notice for stockholders' equity deficiency
----------------------------------------------------------------------------

- Stockholders' equity (deficit) of ~($4.0M) as of March 31, 2025, below Nasdaq's $2.5M minimum.
- Also failed market value ($35M) and net income ($0.5M) alternatives.
- Company has 45 calendar days to submit a plan to regain compliance; Nasdaq may grant up to 180 days.
- Bempikibart-related liability of $55M from Amgen re-acquisition contributes to deficit.
- No immediate effect on listing; stock continues trading under QTTB.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1661998/000119312525125435/0001193125-25-125435-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1661998/000119312525125435/d842247d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-125435

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer